3 weird ways to keep your brain healthy — one you can do in the shower
Our noggins take a floggin' with age, leading to reduced brain volume, less effective communication between neurons and decreased blood flow. These changes can affect learning, memory, processing speed and other cognitive functions.
Now, you probably already know that eating a healthy diet, exercising regularly, getting adequate sleep, managing stress and staying socially connected can help keep brains young.
There are also some offbeat strategies to engage your brain — you can learn an instrument, use your non-dominant hand for tasks and take a different route home.
Harvard-trained neuroscientist Kevin Woods — director of science at Brain.fm, a music streaming service designed to influence brainwave activity — has three other simple suggestions to complement healthy routines. No brainstorm required.
Chewing gum can feed the brain in a number of ways, though the exact mechanisms are unclear.
Some studies propose that chewing gum increases blood flow to the brain, which means more oxygen and glucose for the prefrontal cortex and hippocampus, areas vital for memory and learning.
This increased blood flow can also enhance focus and attention and reduce stress and anxiety.
As for types of gum, Woods told The Post that 'it should be a gum with decent flavor that doesn't fade too quickly — and one that doesn't fall apart over time.'
A dentist might recommend a sugar-free gum that doesn't harm teeth.
There could be an even better, if not unconventional, option. A recent study found that chewing hard substances like a wood pencil can boost levels of the antioxidant glutathione in the brain — chewing gum did not provide the same effect.
If you're worried about splinters, tooth damage and digestive issues with wooden material, leave it to beavers.
'Backward walking enhances brain health by challenging the brain, focusing attention and strengthening neural connections while potentially forming new pathways,' Woods said.
'Studies have found that backward walking increases cognitive control and even memory recall,' he added.
Also known as retro walking, this practice can improve balance, coordination and posture, strengthen certain muscles, reduce lower back pain and burn more calories than walking forward.
Experts recommend starting slowly, choosing a path free of obstacles and uneven pavement, keeping the head and torso upright, engaging the core, stepping toes first and being mindful of surroundings.
Humming can ease stress and promote relaxation by stimulating the vagus nerve, a complex network of over 200,000 fibers that connects the brain and major organs.
Research indicates that humming can also increase nitric oxide levels in the nasal cavity, potentially improving blood flow to the brain and elevating mood.
'Studies on choir singers show enhanced heart rate variability and cognitive function,' Woods explained. 'Plus, the breath control required for sustained notes exercises the same neural networks involved in attention regulation.'
Woods recommends doing these three activities often, finding a consistent routine that works for you.
Since the brain is the control center for thinking, feeling and acting, taking care of it is crucial for overall health and well-being.
'While science can tell us useful things to try, to some extent, different brains need different things to focus best,' Woods said.
'What you find helpful, someone else may find distracting,' he added. 'So don't be afraid to test what works best for you!'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott's future dual glucose-ketone sensor in the US. The collaboration aims to enhance real-time decision-making support for individuals with diabetes. The iLet Bionic Pancreas received FDA clearance in May 2023 and is distinguished as the first and only AID system that autonomously makes 100% of insulin dosing decisions. This eliminates the need for carb counting or manual insulin correction calculations for users, though they still need to be 'carb aware.' The system currently supports Abbott's FreeStyle Libre 3 Plus continuous glucose monitoring sensor, and the new agreement deepens the ongoing partnership between Beta Bionics and Abbott. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The new dual sensor is currently under development and is built on the same form factor as Abbott's FreeStyle Libre 3 Plus and will continuously monitor both glucose and ketone levels. Ketone monitoring is a crucial advancement as it can help detect early signs of diabetic ketoacidosis, which is a serious complication of diabetes. Abbott's dual glucose-ketone sensor has received FDA breakthrough device designation. Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells health care products. Beta Bionics Inc. (NASDAQ:BBNX) is a commercial-stage medical device company. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies
BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to buy now. On June 18, BrightSpring Health Services announced that its specialty pharmacy, called Onco360, has been chosen as the national pharmacy partner for several newly approved therapies. These innovative treatments target advanced cancers and rare genetic disorders. BrightSpring delivers care and clinical solutions to 400,000+ customers, clients, and patients daily across all 50 states. Onco360 will provide access, education, data, and expert support for patients suffering from advanced ovarian and lung cancers, as well as neurofibromatosis type 1. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. Onco360 has been selected as a pharmacy partner for the following specific medication therapies: GOMEKLI, which is approved for adult and pediatric patients aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas/PN not suitable for complete resection; AVMAPKI FAKZYNJA CO-PACK, which is approved for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer/LGSOC who have received prior systemic therapy; and IBTROZI, which is approved for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that operates through 2 segments: Pharmacy Solutions and Provider Services. Onco360 is a national, independent Oncology Pharmacy and clinical support services company. While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Waystar Study Highlights AI's Critical Role, Proven ROI in Healthcare Payments
Waystar Holding Corp. (NASDAQ:WAY) is one of the best new stocks to buy now. On June 23, Waystar announced the findings of a commissioned study conducted by Forrester Consulting. The study is titled 'AI in Healthcare Payments Software: A Strategic Imperative,' and revealed that AI is becoming increasingly critical in revenue cycle management/RCM due to its proven impact and measurable ROI. The research shows acceleration in AI adoption within healthcare. 82% of healthcare leaders now consider AI an integral part of their RCM operations, with 70% identifying it as a top organizational priority. The study also found that AI is delivering improvements in key revenue cycle metrics, such as a 13% to 37% improvement in high-impact areas such as claim accuracy, denial prevention, workforce efficiency, and payment speed. A medical professional with a patient explaining the effects of neurostimulation treatments. Trust in AI is growing, with 60% of decision-makers reporting increased confidence since implementing AI. ~ 70% of healthcare leaders view AI as a high or critical organizational priority, and 60% plan to increase their AI investment. The study is based on responses from 300+ healthcare leaders and highlights a preference for existing RCM software partners when it comes to AI capabilities. Waystar serves ~30,000 clients and represents over 1 million distinct providers, including 16 of the top 20 institutions on the US News Best Hospitals list. Waystar Holding Corp. (NASDAQ:WAY) develops a cloud-based software solution for healthcare payments. While we acknowledge the potential of WAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data